CrushSCI.com
35.5Average days
33Median days
8Fastest days
110Longest days
1,2982025 publications

Paper Review Records

All Paper Review Records

25 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

8 days

Pediatric Outpatient Fluoroquinolone Dispensing After EMA/AIFA Safety Restrictions: A Regional Interrupted Time-Series Analysis from Southern Italy

Authors
Maurizio Aricò; Cataldo Procacci; Pasquale Stefanizzi; Claudia Palmieri; Silvio TafuriShow moreShow less
Affiliations
1. Interdisciplinary Department of Medicine, Aldo Moro University of Bari, 70121 Bari, Italy; 2. Pharmaceutical Department, Barletta-Andria-Trani Local Health Authority, 76125 Trani, ItalyShow moreShow less
Source PDF DOI Publisher page
10 days

Vulvovaginal Infections in Saudi Arabia: Prevalence in Clinically Sampled and Screened Populations, Aetiology and Antimicrobial Resistance: A Systematic Review and Meta-Analysis

Authors
Yazeed Albalawi; Mohammad ZubairShow moreShow less
Affiliations
1. Department of Obstetrics and Gynaecology, Faculty of Medicine, University of Tabuk, Tabuk 71491, Saudi Arabia; 2. Department of Medical Microbiology, Faculty of Medicine, University of Tabuk, Tabuk 71491, Saudi Arabia; 3. Molecular Microbiology and Infectious Disease Research Unit, University of Tabuk, Tabuk 71491, Saudi ArabiaShow moreShow less
Source PDF DOI Publisher page
33 days

Long-Acting Lipoglycopeptides in Orthopedic and Cardiovascular Device-Associated Infections: Outcomes According to Source-Control Strategy in a Multicenter Day-Hospital Cohort

Authors
Andrea Marino; Emmanuele Venanzi Rullo; Giuseppe Pipitone; Alessandro Giorgio Geremia; Andrea De Vito; Antonio Albanese; Nicholas Geremia; Alessandro Franzò; Barbara Bellocchi; Eugenia Pistarà; Paolo Italia; Bianca Catania; Andrea Buzzi; Laura Santoro; Serena Spampinato; Chiara Iaria; Giordano Madeddu; Carmelo Iacobello; Rosa Manuele; Fabrizio Pulvirenti; Bruno Cacopardo; Giuseppe NunnariShow moreShow less
Affiliations
1. Infectious Diseases Unit, Department of Clinical and Experimental Medicine, ARNAS Garibaldi Hospital, University of Catania, 95122 Catania, Italy; 2. Unit of Infectious Diseases, Department of Clinical and Experimental Medicine, University of Messina, 98125 Messina, Italy; 3. Infectious Diseases Unit, ARNAS Civico-Di Cristina, 90127 Palermo, Italy; 4. Unit of Infectious Diseases, “G. Rodolico-S. Marco” University Hospital, University of Catania, 95121 Catania, Italy; 5. Unit of Infectious Diseases, Department of Medicine, Surgery and Pharmacy, University of Sassari, 07100 Sassari, Italy; 6. Infectious Diseases Unit, Ospedale Papardo, 98158 Messina, Italy; 7. Unit of Infectious Diseases, Department of Clinical Medicine, Ospedale “dell’Angelo”, 30174 Venice, Italy; 8. Unit of Infectious Diseases, Department of Clinical Medicine, Ospedale Civile “S.S. Giovanni e Paolo”, 30122 Venice, Italy; 9. Unit of Infectious Diseases, Ospedale Cannizzaro, 95126 Catania, Italy; 10. Unit of Infectious Diseases, Ospedale Vittorio Emanuele, ASP Caltanissetta, 93012 Gela, ItalyShow moreShow less
Source PDF DOI Publisher page
38 days

Changes in Rectal Swab Surveillance Activity and Multidrug-Resistant Organism Colonisation Positivity Before and During the COVID-19 Pandemic in a Tertiary-Care Hospital

Authors
Juan José Gualda-Gea; Isabel Torá-Rocamora; Ignasi Roca; Elisa Rubio; Lourdes Estefanía Barón-Miras; Romina Parejo; Blanca Torralbo; Isabel Fortes; Gloria Puig; Elisabet Llorens; Gemina Santana; Cristina Pitart; José Antonio Martinez; Maria Jesús BertranShow moreShow less
Affiliations
1. Department of Preventive Medicine and Epidemiology, Clínic Barcelona, 08036 Barcelona, Spain; 2. Department of Medicine, Faculty of Medicine, University of Barcelona, 08036 Barcelona, Spain; 3. Data Management and Analytics Unit, ICMiD, Clínic Barcelona, 08036 Barcelona, Spain; 4. Department of Clinical Microbiology, Biomedical Diagnostic Center (CDB), Clínic Barcelona, 08036 Barcelona, Spain; 5. Barcelona Institute for Global Health, 08036 Barcelona, Spain; 6. Department of Infectious Diseases, Clínic Barcelona, 08036 Barcelona, SpainShow moreShow less
Source PDF DOI Publisher page
46 days

Oxford Nanopore-Based Genomic Characterization of Macrolide Resistance in Clinical Streptococcus pyogenes Isolates

Authors
Serkan Kaydaş; Asuman Akar; Ayla Behnejad Kazancık; Nida ÖzcanShow moreShow less
Affiliations
1. Central Laboratory, Kızıltepe State Hospital, Mardin 47400, Turkey; 2. Department of Pediatrics, Faculty of Medicine, Dicle University, Diyarbakır 21200, Turkey; 3. Department of Medical Microbiology, Faculty of Medicine, Dicle University, Diyarbakır 21200, TurkeyShow moreShow less
Source PDF DOI Publisher page
24 days

Antibiotic Resistance in Urine Culture Isolates from Hospitalized Children Under Five Years with Urinary Tract Infection: A Comparison of the 2019–2020 and 2024–2025 Periods

Authors
Elife Çapan Gün; Şeyma Şimşirgil Kara; Yasemin AkınShow moreShow less
Affiliations
1. Department of Pediatrics, Kartal Dr. Lütfi Kırdar City Hospital, Istanbul 34890, Türkiye; 2. Faculty of Health Sciences, Sinop University, Sinop 57000, TürkiyeShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does Antibiotics-Basel take to review a manuscript?

As of 2026-11-18, CrushSCI has 25 complete review records for Antibiotics-Basel. The fastest paper went from submission to acceptance in 8 days (Pediatric Outpatient Fluoroquinolone Dispensing After EMA/AIFA Safety Restrictions: A Regional Interrupted Time-Series Analysis from Southern Italy, received 2026-11-03, accepted 2026-11-11); the slowest took 110 days. The average is 35.5 days and the median is 33 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.